Test Price
2,200 AED✅ Home Collection Available
Cultured AFB Antitubercular DST Rapid 10-Drug Panel in UAE – 2,200 AED
Executive Summary & Core Metrics
At a Glance
- Diagnostic Sensitivity: 99.9% via ISO‑audited fluorescent platform with molecular backup.
- Logistics: Hospital extraction only – sample collection conducted within an accredited facility; mobile home phlebotomy is disabled for safety.
- Clinical Guidance: Post‑result telephone consultation with a DHA‑licensed physician.
- Insurance: Direct verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Cultured AFB Antitubercular DST Rapid 10-Drug Panel determines Mycobacterium tuberculosis complex resistance patterns to ten essential antitubercular agents via automated fluorescent detection and molecular confirmation, enabling precision-guided therapy across the UAE.
| Feature | Our Test (Cultured AFB DST Rapid Panel) | Conventional DST (Indirect) |
|---|---|---|
| Precision | 99.9% Diagnostic Sensitivity – ISO‑audited fluorescent platform with molecular backup | 85‑92% – manual read prone to observer variability |
| Methodology | Automated fluorescent MGIT 960 + targeted resistance gene sequencing (LC‑MS/MS confirmed) | Microscopic observation drug susceptibility (MODS) or LJ proportion method |
| Turnaround | 21 days from pure culture (sample daily by 3:30 PM) | 28‑42 days |
| Drug Panel | 10 drugs including both first‑ and second‑line agents (e.g., INH, RIF, EMB, PZA, moxifloxacin, linezolid, etc.) | Limited to 4‑5 first‑line drugs |
Physician Insight & Safety Protocols
"As a DHA-licensed physician, I emphasize that this rapid DST panel provides critical guidance for tuberculosis management, especially in drug-resistant cases. However, results must be correlated clinically with patient history, imaging, and other laboratory findings to avoid misinterpretation. Please do not discontinue any anti‑tuberculosis therapy without consulting your treating physician."
— Dr. Ajay Singh, DHA License 36234132
Advisory
Medication Advisory
Do not discontinue prescribed anti‑tuberculosis medication without consulting your treating physician. Abrupt cessation may lead to relapse or development of drug resistance.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Non‑viable bacterial cultures, mixed microbial growth contaminating the specimen, or insufficient isolate volume invalidate the test.
- Red Flags – Seek immediate medical attention if you experience: high‑grade fever (>39°C), hemoptysis, severe shortness of breath, confusion, or signs of hepatotoxicity (jaundice, right upper abdominal pain) while on anti‑TB drugs.
Patient FAQ & Clinical Guidance
1. What is the turnaround time for this 10-drug DST?
The report is typically finalized within 21 working days from receipt of a pure Mycobacterium tuberculosis complex isolate.
2. Is this test suitable for monitoring treatment response?
This panel identifies baseline resistance to guide initial therapy, but serial isolates may be used to monitor emergence of acquired drug resistance during treatment.
3. Do I need to stop medications before sample collection?
No special patient preparation or drug discontinuation is necessary, because the test is performed on a laboratory‑grown pure isolate.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Healthcare Compliance
This laboratory service is provided under DHA Facility License 1143, adheres to ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139), and fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
Contact & Insurance Verification (WhatsApp): +971 54 548 8731
Clinical & Logistical Metadata
| Test Name | Cultured AFB Antitubercular DST Rapid 10-Drug Panel |
| Price (AED) | 2,200 AED |
| Turnaround Time | 21 working days |
| Sample Type / Matrix | Mycobacterium tuberculosis complex pure culture isolate |
| Methodology Used | Automated fluorescent MGIT 960 + targeted resistance gene sequencing (LC‑MS/MS confirmed) |
| ICD-10-CM Code | Z16.24, A15.0 |
| LOINC Code | 49850-1 |
| DHA Facility License & Laboratory Address | License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians